Back to search

Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2 interferon in patients with malignancies

Data up to Jan 2025

Published1984
Citations24
References19

Total Citations Per Year

Abstract

References (19)

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

1977 • 696 citations

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1980 • 503 citations

Quantitative studies on viral interference in suspended L cells

1962 • 395 citations

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1982 • 381 citations

PRIMARY SEX-RATIO AND SIZE OF FAMILY

1970 • 366 citations

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1978 • 267 citations

Interferon: Immunobiology and Clinical Significance

1982 • 177 citations

Human Leukocyte Interferon for the Treatment of Varicella in Children with Cancer

1982 • 169 citations

Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis

1978 • 159 citations

A Multiple-Dose Phase I Trial of Recombinant Leukocyte A Interferon in Cancer Patients

1982 • 151 citations

Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma

1981 • 120 citations

Human leukocyte interferon preparation blocks granulopoietic differentiation

1979 • 98 citations

Human Interferon Therapy for Herpes Zoster in Adults

1975 • 74 citations

Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity.

1981 • 63 citations

Towards tumor therapy with interferons, Part I. Interferons: production and properties

1980 • 41 citations

Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect

1976 • 33 citations

Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferon.

1982 • 18 citations

Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.

1982 • 16 citations

How they did it: the synthesis of interferon

1980 • 2 citations

Cited By (0)

Loading...
Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2… (1984) – American Journal of Hematology | Metascience Observatory Explorer